Macrodissection

Enrichment improves how closely the extracted material represents the target lesion. If normal cells, necrotic tissue, or stroma contribute heavily to a specimen, their nucleic acids may dilute signals from tumor cells. Removing those non-target regions before extraction increases the relative contribution of tumor-derived material, which can make mutation, expression, and biomarker measurements more reliable.

The stained section serves as the visual guide, while the adjacent unstained section supplies the material for downstream extraction. A pathologist or trained researcher matches the regions between sections and selects the corresponding tumor area. This pairing links recognizable tissue features with the sample actually processed, helping target selection remain grounded in the specimen’s cellular and structural context.

Macrodissection is appropriate when manual enrichment is sufficient for the research question. It provides a practical alternative when laser-capture microdissection is unnecessary or unavailable, allowing investigators to isolate a selected tissue region without relying on that specialized approach. The choice therefore depends on the required sampling approach and the resources available for the study.

A typical workflow begins with review of a stained tissue section to identify the tumor region. The corresponding area is then located on an adjacent unstained section and removed manually by scraping, cutting, or using a punch tool. The isolated material proceeds to nucleic-acid extraction, creating a sample enriched for the selected tissue before molecular analysis.

Quality depends on selecting the intended tumor region and limiting contributions from normal cells, necrotic tissue, and stroma. Accurate visual identification is therefore important because the extracted material reflects the area removed from the unstained section. When non-target tissue is reduced, the resulting nucleic-acid preparation is more representative of the tumor-related material under investigation.

Material prepared by this approach can support mutation testing, gene-expression studies, and biomarker assessment. Its main value is improving the reliability of these molecular measurements by reducing contamination from tissues that are not the primary subject of analysis. This makes targeted tissue sampling relevant when researchers need molecular results that better reflect selected tumor areas.